As we have recently shown, using the multiplex citrullinated peptide array, ACPA fine-specificities can be detected in a substantial proportion (16%) of the anti-CCP2-negative EIRA RA population [19], also in line with previous data [16, 17]. Here, AGBL2 is linked to rheumatoid arthritis.